WINDTREE THERAPEUTICS INC /DE/

WINT

WINDTREE THERAPEUTICS INC /DE/

WINT

Insider Sentiment (TTM):

Last Purchase:2024-10-08Last Sale:2021-12-30Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2025-06-30Institutional Shares Owned:16,960Shares Outstanding:4,877,257Institutional Ownership Pct.:0.35%

Earnings Market Reaction:

Filing Date:2025-11-19Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Cash And Cash Equivalents At Carrying Value	0	0	1	2	2	2	3	4	7	11	4	6
Assets Current
Assets Current	7	7	2	3	4	2	3	5	9	13	5	7
Prepaid Expense And Other Assets Current	1	0	0	1	2	0	1	1	2	2	1	1
Notes And Loans Receivable Net Current	6	5	-	-	-	-	-	-	-	-	-	-
Deposits Assets Current	-	1	-	-	-	-	-	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Restricted Cash And Cash Equivalents Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	2	2	2	2
Indefinite Lived Intangible Assets Excluding Goodw…	8	24	24	24	25	25	25	25	25	25	25	25
Goodwill	-	-	-	-	-	-	-	0	0	0	3	3
Assets	16	32	27	28	30	29	30	32	36	41	35	38
Accounts Payable Current	2	4	3	2	2	3	2	1	1	1	1	0
Accrued Liabilities Current	2	2	2	2	2	2	2	2	2	2	2	2
Operating Lease Liability Current	1	1	1	1	0	0	0	0	0	0	0	0
Liabilities Current
Liabilities Current	22	16	6	6	14	9	5	4	4	4	3	2
Senior Notes Current	-	-	-	-	-	0	-	-	-	-	-	-
Convertible Notes Payable Current	3	8	-	-	-	-	-	-	-	-	-	-
Loans Payable Current	0	0	0	0	0	0	0	0	0	1	0	0
Other Liabilities Current	0	0	0	0	1	1	1	1	-	-	-	0
Operating Lease Liability Noncurrent	0	0	1	1	1	1	1	1	1	1	2	2
Other Liabilities Noncurrent	4	4	4	4	4	4	4	4	4	4	4	4
Deferred Income Tax Liabilities Net	2	5	5	5	5	5	5	5	5	5	5	5
Liabilities	28	25	15	15	24	18	15	29	29	29	28	28
Temporary Equity
Temporary Equity Carrying Amount Attributable To P…	0	3	1	3	2	7	-	0	-	-	-	-
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	881	868	864	860	856	853	853	851	850	850	839	838
Stockholders Equity
Stockholders Equity	-12	4	10	10	4	3	15	3	7	12	7	10
Treasury Stock Value	-	-	-	-	-	-	-	-	-	-	-	-3
Retained Earnings Accumulated Deficit	-889	-861	-851	-847	-849	-847	-835	-845	-840	-835	-829	-825
Treasury Stock Common Value	-3	-3	-3	-3	-3	-3	-3	-3	-3	-3	-3	-3
Liabilities And Stockholders Equity	16	32	27	28	30	29	30	32	36	41	35	38
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	120	120	120	120	120	120	120	120	120	120	120	120
Common Stock Shares Issued	34	9	4	0	0	0	0	7	0	0	0	0
Shares Outstanding	34	9	4	0	0	0	0	7	0	0	0	0
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	-31.55%	11.95%	-27.70%	-87.33%	-62.71%	-85.50%	12.65%	-38.78%	-79.59%	-	-	-
2024	-31.10%	-30.89%	83.00%	-71.18%	-93.50%	-94.68%	-43.19%	-61.12%	-75.62%	-27.78%	-51.86%	-21.25%
2023	18.79%	-15.44%	-11.41%	-10.61%	-28.14%	-21.59%	3.96%	-28.81%	-57.43%	-45.96%	-58.22%	-58.09%
2022	-	-	-	-	-	-	-	-	-	-55.71%	-70.14%	-70.94%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	0.33	0.43	0.25	0.45	0.27	0.23	0.67	1.35	2.40	3.51	1.89	3.00
Quick Ratio	0.27	0.42	0.18	0.31	0.16	0.21	0.51	1.08	1.99	3.02	1.53	2.51
Working Capital	-14.70M	-8.94M	-4.88M	-3.14M	-10.50M	-6.72M	-1.65M	1.38M	5.20M	9.53M	2.46M	4.92M
Leverage & Debt
Debt to Equity	-2.38	6.93	1.50	1.47	5.42	5.23	0.95	8.56	3.82	2.50	4.01	2.79
Interest Coverage TTM	-68.64	-87.00	-106.71	-111.23	-137.40	-172.34	-408.06	-411.94	-518.63	-507.88	-715.21	-779.87
Debt Ratio	1.73	0.78	0.58	0.53	0.78	0.64	0.49	0.90	0.79	0.71	0.80	0.74
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Free Cash Flow Per Share TTM	-0.57	-3.12	-0.01	-0.29	-0.86	-1.11	-1.49	-3.13	-2,319.06	-3,012.28	-15,902.08	-1,544.84
Dividend Per Share TTM	0.01	0.15	0.00	0.01	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	272.08%	28.76%	169.27%	-91.19%	-56.87%	-53.46%	-83.06%	-48.25%	-41.70%	-47.67%	-47.32%	-42.03%
EPS Growth (1Y)	147.44%	203.52%	-97.70%	-99.28%	-99.99%	-99.98%	-100.00%	-99.85%	26.99%	36.42%	521.20%	-54.45%
Valuation Metrics
P/E TTM	-0.05	-0.17	-85.45	-513.91	-197.96	-162.09	-496.79	-137.13	-0.20	-0.21	-0.12	-2.46
P/B TTM	-0.15	0.70	133.29	91.87	480.82	528.12	192.04	820.56	0.65	0.43	0.61	9.63
Market Cap	1.80M	2.52M	1.37B	918.36M	2.12B	1.85B	2.96B	2.78B	4.88M	5.04M	4.31M	96.39M
Enterprise Value	4.29M	10.00M	1.37B	916.92M	2.12B	1.84B	2.96B	2.78B	-2.01M	-5.73M	76.36K	90.47M
Calculated Values
Free Cash Flow TTM	-15.12M	-15.19M	-14.87M	-15.41M	-15.30M	-12.72M	-13.88M	-13.45M	-13.27M	-13.50M	-15.27M	-19.47M
Net Debt	2.50M	7.48M	-1.01M	-1.45M	-1.86M	-1.80M	-2.55M	-4.09M	-6.90M	-10.77M	-4.24M	-5.92M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-10-08Purchase

Owner: Fraser, Craig

Title: President and CEO

Shares: 5,431

Price/Share: $0.91

Value: $4,942.21

Shares Owned: 8,638

Relationship: Director,Officer

Ownership: Direct

2023-09-27Purchase

Owner: Fraser, Craig

Title: President and CEO

Shares: 2,500

Price/Share: $1.02

Value: $2,550.00

Shares Owned: 57,877

Relationship: Director,Officer

Ownership: Direct

2023-09-26Purchase

Owner: Fraser, Craig

Title: President and CEO

Shares: 2,500

Price/Share: $0.90

Value: $2,250.00

Shares Owned: 55,377

Relationship: Director,Officer

Ownership: Direct

2023-04-26Purchase

Owner: Fraser, Craig

Title: President and CEO

Shares: 1,497

Price/Share: $1.77

Value: $2,649.69

Shares Owned: 7,010

Relationship: Director,Officer

Ownership: Direct

2023-04-25Purchase

Owner: Fraser, Craig

Title: President and CEO

Shares: 1,315

Price/Share: $1.89

Value: $2,485.35

Shares Owned: 5,513

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-10-08	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	5,431	0.91	$4,942.21	8,638	4
2023-09-27	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	2,500	1.02	$2,550.00	57,877	4
2023-09-26	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	2,500	0.90	$2,250.00	55,377	4
2023-04-26	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	1,497	1.77	$2,649.69	7,010	4
2023-04-25	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	1,315	1.89	$2,485.35	5,513	4
2022-07-27	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	2,500	0.38	$950.00	226,558	4
2022-07-26	Hamill, John P.	Officer	SVP & CFO	Direct	Purchase	3,000	0.37	$1,110.00	72,800	4
2022-07-26	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	2,500	0.37	$925.00	224,058	4
2022-06-30	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	4,500	0.43	$1,935.00	221,558	4
2022-06-29	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	7,000	0.42	$2,940.00	217,058	4
2022-03-16	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	2,000	0.98	$1,960.00	210,058	4
2022-03-15	Simonson, Steven	Officer	SVP, Chief Medical Officer	Direct	Purchase	5,000	1.00	$5,000.00	83,602	4
2022-03-15	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	3,000	0.98	$2,940.00	208,058	4
2021-12-30	Bioengine, Capital Inc.	TenPercentOwner	-	Direct	Sale	1,239,088	1.60	$1,982,540.80	0	4
2021-12-30	Center, Laboratories, Inc…	TenPercentOwner	-	Direct	Purchase	1,239,088	1.60	$1,982,540.80	1,239,088	4
2021-11-19	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	930	1.60	$1,488.00	38,158	4
2021-11-18	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	930	1.61	$1,497.30	37,228	4
2021-10-22	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	3,000	1.90	$5,700.00	36,298	4
2021-10-19	Fraser, Craig	Director,Officer	President and CEO	Direct	Purchase	3,000	1.91	$5,730.00	33,298	4
2021-10-19	Huang, James	Director	-	Direct	Purchase	50,000	1.90	$95,000.00	291,281	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-06-30

0.35%

Inst. Shares: 16,960

Shares Outstanding: 4,877,257

2025-03-31

0.00%

Inst. Shares: 45,265

Shares Outstanding: 1,088,564,000

2024-12-31

0.58%

Inst. Shares: 302,640

Shares Outstanding: 52,583,000

2024-09-30

0.92%

Inst. Shares: 163,045

Shares Outstanding: 17,740,000

2024-06-30

0.01%

Inst. Shares: 1,516

Shares Outstanding: 11,497,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-06-30	16,960	4,877,257	0.35%
2025-03-31	45,265	1,088,564,000	0.00%
2024-12-31	302,640	52,583,000	0.58%
2024-09-30	163,045	17,740,000	0.92%
2024-06-30	1,516	11,497,000	0.01%
2024-03-31	674,611	9,295,000	7.26%
2023-12-31	231,071	4,300,000	5.37%
2023-09-30	207,973	286,000	72.72%
2023-06-30	45,942	224,000	20.51%
2023-03-31	372	48,000	0.78%
2022-12-31	788,888	630,000	125.22%
2022-09-30	1,683,261	623,000	270.19%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

WINDTREE THERAPEUTICS INC /DE/ (WINT) — SEC Financial Statements & Analysis

WINDTREE THERAPEUTICS INC /DE/ (WINT) is a biological products, (no diagnostic substances) company, incorporated in DE. WINDTREE THERAPEUTICS INC /DE/ trades on OTC as: WINT, WINTW. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), WINDTREE THERAPEUTICS INC /DE/ reported a Debt-to-Equity ratio of -2.38x, a Price-to-Book (P/B) ratio of -0.15x (TTM), at a market cap of $1.80M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -2.38x
P/B TTM: -0.15x
Market Cap: $1.80M

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is WINDTREE THERAPEUTICS INC /DE/ in?

WINDTREE THERAPEUTICS INC /DE/ (WINT) operates in the Biological Products, (No Diagnostic Substances) industry.

What is WINT's market cap?

WINDTREE THERAPEUTICS INC /DE/ (WINT) has a market capitalization of $1.80M as of 2025-09-30.

What exchange does WINT trade on?

WINDTREE THERAPEUTICS INC /DE/ (WINT) trades on the OTC.

Where is WINDTREE THERAPEUTICS INC /DE/ incorporated?

WINDTREE THERAPEUTICS INC /DE/ is incorporated in DE.